Discover a new article in which our CEO Tuomas Tenkanen presents Mobidiag solutions for antibiotic resistance and the recent news in the company.
Mobidiag aims at developing innovative molecular diagnostics for antibiotic resistance – read our CEO’s latest interview on the topic and the company’s future plans.
Read full article in Finnish by clicking here.
